| Symbol | CPIX |
|---|---|
| Name | CUMBERLAND PHARMACEUTICALS INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Pharmaceutical Preparations |
| Address | 1600 WEST END AVENUE, NASHVILLE,, TN 37203 |
| Telephone | 615-255-0068 |
| Fax | — |
| — | |
| Website | https://www.cumberlandpharma.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001087294 |
| Description | Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. The companys primary target markets are hospital acute care, gastroenterology, rheumatology and oncology. The company promotes its approved products through its hospital, field and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The companys revenue is derived primarily from the product sales of FDA approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, RediTrex, Sancuso, Vaprisol and Vibativ.. Additional info from NASDAQ: |
2026-05-05 21:07
(30% Negative) CUMBERLAND PHARMACEUTICALS INC (CPIX) Reports Q2 2026 Financial Results
Read more
2026-04-28 20:05
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
Read more
2026-04-24 21:08
(99% Neutral) CUMBERLAND PHARMACEUTICALS INC (CPIX) Announces Regulatory Update
Read more
2026-04-23 13:01
(90% Positive) CUMBERLAND PHARMACEUTICALS INC (CPIX) Announces Enrollment Update for pharmaceuticals Due to Pandemic-Related Challenges, Patient Enrollment Issues, Safety Review, Efficacy Assessment
Read more
2026-04-23 10:03
New Form DEFA14A - CUMBERLAND PHARMACEUTICALS INC <b>Filed:</b> 2026-04-23 <b>AccNo:</b> 0001104659-26-047338 <b>Size:</b> 735 KB
Read more
2026-03-09 18:04
New Form DEFA14A - CUMBERLAND PHARMACEUTICALS INC <b>Filed:</b> 2026-03-09 <b>AccNo:</b> 0001087294-26-000027 <b>Size:</b> 59 KB
Read more
2026-03-09 18:02
New Form DEF 14A - CUMBERLAND PHARMACEUTICALS INC <b>Filed:</b> 2026-03-09 <b>AccNo:</b> 0001087294-26-000025 <b>Size:</b> 1 MB
Read more
2026-03-03 22:10
(30% Negative) CUMBERLAND PHARMACEUTICALS INC (CPIX) Reports Q1 2026 Financial Results
Read more
2026-02-24 21:05
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07387666 | Imaging Acetadote Metabolism in Glioblastoma | Early_Phase1 | Glioblastoma | Not_Yet_Recruiting | 2026-07-01 | 2028-07-01 | ClinicalTrials.gov |
| NCT06119061 | Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With Extern… | Phase4 | Subarachnoid Hemorrhage, Aneurysmal | Recruiting | 2024-07-02 | 2026-12-01 | ClinicalTrials.gov |
| NCT05571059 | Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) | Phase2 | Idiopathic Pulmonary Fibrosis | Recruiting | 2024-01-31 | 2027-01-01 | ClinicalTrials.gov |
| NCT03340675 | Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy | Phase2 | Duchenne Muscular Dystrophy Cardiomyopathy | Completed | 2020-10-19 | 2026-01-23 | ClinicalTrials.gov |
| NCT03962855 | Thromboxane Receptor Antagonist to Improve Endothelial Function | Phase2 | Cardiovascular Diseases | Completed | 2019-09-20 | 2022-11-15 | ClinicalTrials.gov |
| NCT03694249 | Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Meta… | Phase2 | Malignant Solid Tumor | Active_Not_Recruiting | 2018-12-12 | 2026-04-01 | ClinicalTrials.gov |
| NCT03611010 | Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in… | Phase2 | Hypercholesterolemia | Completed | 2018-08-07 | 2020-02-24 | ClinicalTrials.gov |
| NCT03494556 | Prehospital Translation of Chest Pain Tools | — | Acute Coronary Syndrome | Completed | 2018-04-18 | 2020-09-09 | ClinicalTrials.gov |
| NCT02583399 | Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients | Phase4 | Pain | Completed | 2017-08-08 | 2019-07-02 | ClinicalTrials.gov |
| NCT03172793 | Telavancin Pharmacokinetics in Cystic Fibrosis Patients | Phase4 | Cystic Fibrosis | Completed | 2017-08-08 | 2019-04-17 | ClinicalTrials.gov |
| NCT03028350 | Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD) | Phase2 | Asthma, Aspirin-Induced | Completed | 2017-07-17 | 2023-04-25 | ClinicalTrials.gov |
| NCT02802228 | Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypert… | Phase2 | Portal Hypertension | Completed | 2017-03-06 | 2018-07-17 | ClinicalTrials.gov |
| NCT02682511 | Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-assoc… | Phase2 | Scleroderma, Diffuse | Active_Not_Recruiting | 2017-01-01 | 2026-08-01 | ClinicalTrials.gov |
| NCT02208063 | A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial | Phase3 | Bacteremia | Terminated | 2014-12-01 | 2018-04-12 | ClinicalTrials.gov |
| NCT02013141 | Telavancin Pediatric PK Study (Ages >12 Months to 17 Years) | Phase1 | Gram-Positive Bacterial Infections | Terminated | 2014-12-01 | 2021-03-01 | ClinicalTrials.gov |
| NCT02288234 | Telavancin Observational Use Registry (TOUR) | — | Hospital Acquired Bacterial Pneumonia | Completed | 2014-11-01 | 2017-10-01 | ClinicalTrials.gov |
| NCT02216357 | Trial to Determine the Safety of Oral Ifetroban in Patients With a History of A… | Phase2 | Aspirin Exacerbated Respiratory Disease (AERD) | Completed | 2014-08-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT02123017 | Efficacy and Safety of Bisacodyl and Lactulose as a Preparation for Colonoscopy | Phase2 | Colonoscopy Preparation | Completed | 2014-04-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01887470 | 2 Regimens of Lactulose for Colonoscopy Preparation in Adults | Phase2 | Colonoscopy Preparation | Completed | 2013-07-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01901393 | Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Co… | Phase4 | Pain | Completed | 2013-07-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02614937 | Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retin… | Phase1 | Retinal Vein Occlusion | Completed | 2013-04-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01773005 | Caldolor Versus Caldolor Plus OFIRMEV in Total Knee or Hip Arthroplasty Surgeri… | Phase4 | Pain | Completed | 2012-12-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01530880 | Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain H… | Phase4 | Fever | Terminated | 2012-10-01 | 2016-03-17 | ClinicalTrials.gov |
| NCT01707251 | Intravenous Ibuprofen for Laparoscopic Bariatric Surgery | Phase4 | Obesity | Completed | 2012-10-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01650519 | A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Contr… | Phase4 | Arthroscopic Knee Surgery | Completed | 2012-09-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01526551 | A Study to Compare the Impact of a School Based HPV Program on Vaccination Upta… | Na | Human Papillomavirus | Completed | 2012-08-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01650870 | Safety, Efficacy, and Patient Preference of Split-Dose Crystalline Lactulose as… | Phase2 | Colonoscopy | Completed | 2012-07-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01451411 | A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Coni… | Phase3 | Hyponatremia | Terminated | 2012-02-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01514175 | A Pilot Study Comparing the Analgesic Efficacy of IV Ibuprofen and IV Ketorolac | Phase4 | Chronic Pelvic Pain | Unknown | 2012-01-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01436500 | Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients | Phase2 | Hepatorenal Syndrome | Completed | 2011-10-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT01332253 | Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric… | Phase3 | Tonsillectomy | Completed | 2011-07-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01334944 | Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprof… | Phase4 | Pain | Completed | 2011-06-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01334957 | Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenou… | Phase4 | Pain | Completed | 2011-06-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01370148 | A Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokineti… | Phase1 | Liver Disease | Completed | 2011-04-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01297829 | Does Preoperative Caldolor Decrease the Requirement for Postoperative Narcotics | Phase3 | Postoperative Pain | Unknown | 2011-02-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01256541 | Kristalose as Bowel Evacuant Prior to Colonoscopy | Phase1 | Bowel Evacuant Prior to Colonoscopy | Completed | 2010-12-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01238796 | A Study to Evaluate the Effect of Renal Function on the Biological Activity of … | Phase1 | Kidney Diseases | Completed | 2010-12-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01118663 | Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection | Phase3 | Acetaminophen Overdose | Terminated | 2010-09-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01002573 | Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatr… | Phase3 | Fever | Completed | 2010-07-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01130324 | VIBATIV Pregnancy Registry | — | Pregnancy | Withdrawn | 2009-11-01 | 2020-10-01 | ClinicalTrials.gov |
| NCT00712543 | A Preference Study Comparing Kristalose® and Liquid Lactulose | Phase4 | Constipation | Completed | 2009-06-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00843986 | Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acu… | Phase3 | Hyponatremia | Terminated | 2009-04-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00889538 | Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe… | Na | Autism | Completed | 2009-04-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT00887627 | Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate K… | Phase1 | Kidney Diseases | Completed | 2009-04-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00867880 | Pharmacokinetic Study Of Ibuprofen Injection (IVIb) In Healthy Adult Subjects | Phase1 | Healthy | Completed | 2009-03-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00851227 | Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment V… | Phase1 | Liver Disease | Completed | 2009-02-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00592475 | A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the … | Phase2 | Liver Cirrhosis | Completed | 2007-12-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00606489 | Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized A… | Phase3 | Burns | Completed | 2007-11-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00780962 | N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department P… | Phase2 | Radiocontrast Nephropathy | Completed | 2007-10-16 | 2010-08-09 | ClinicalTrials.gov |
| NCT00470743 | Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Art… | Phase4 | Ductus Arteriosus, Patent | Withdrawn | 2007-05-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00470600 | Efficacy and Safety Study of Caldolor (IV Ibuprofen) in Hospitalized Adult Orth… | Phase3 | Pain | Completed | 2007-05-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00478192 | Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects… | Phase3 | Hyponatremia | Completed | 2007-04-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00939913 | Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy | Phase4 | Nephropathy | Unknown | 2007-01-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00435591 | A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic… | Phase4 | Hyponatremia | Completed | 2007-01-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00225706 | A Study of Caldolor in Hospitalized Febrile Pediatric Patients | Phase3 | Fever | Completed | 2005-10-01 | 2007-08-01 | ClinicalTrials.gov |
| NCT00107952 | Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to … | Phase3 | Bacterial Pneumonia | Completed | 2005-02-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00107978 | Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure… | Phase3 | Staphylococcal Skin Infection | Completed | 2005-02-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00091819 | Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure… | Phase3 | Staphylococcal Skin Infection | Completed | 2005-01-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00225732 | Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients | Phase3 | Pain | Completed | 2005-01-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00124020 | Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to … | Phase3 | Bacterial Pneumonia | Completed | 2005-01-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00379847 | An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervo… | Phase3 | Hyponatremia | Completed | 2004-02-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00077675 | Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated G… | Phase2 | Infections, Gram-positive Bacterial | Completed | 2004-02-01 | 2004-09-01 | ClinicalTrials.gov |
| NCT00062647 | Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia | Phase2 | Gram-Positive Bacterial Infections | Completed | 2003-08-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00061633 | Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated G… | Phase2 | Infections, Gram-Positive Bacterial | Completed | 2003-06-01 | 2004-01-01 | ClinicalTrials.gov |
| NCT00057356 | Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompen… | Phase2 | Chronic Heart Failure | Completed | 2002-11-01 | 2004-03-01 | ClinicalTrials.gov |
| NCT01131000 | Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febril… | Phase3 | Fever | Completed | 2002-06-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT00380575 | Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or H… | Phase3 | Hyponatremia | Completed | 2000-08-01 | 2003-02-01 | ClinicalTrials.gov |
| NCT00492037 | Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervol… | Phase3 | Hyponatremia | Completed | 2000-01-01 | 2002-02-01 | ClinicalTrials.gov |
Total clinical trials: 68
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Vibativ | Other | Preclinical | Hospital Acquired Bacterial Pneumonia | COMPLETED | NCT02288234 |
| Cefazolin | Other | Phase PHASE3 | Bacteremia | TERMINATED | NCT02208063 |
| Synthetic penicillin | Other | Phase PHASE3 | Bacteremia | TERMINATED | NCT02208063 |
| Daptomycin | Other | Phase PHASE3 | Bacteremia | TERMINATED | NCT02208063 |
| Vancomycin | Other | Phase PHASE3 | Bacteremia | TERMINATED | NCT02208063 |
| Telavancin | Other | Phase PHASE3 | Bacteremia | TERMINATED | NCT02208063 |
| Normal Saline | Other | Phase PHASE3 | Fever | COMPLETED | NCT01131000 |
| Ibuprofen | Other | Phase PHASE3 | Fever | COMPLETED | NCT01131000 |
| Kristalose | Other | Phase PHASE1 | Bowel Evacuant Prior to Colonoscopy | COMPLETED | NCT01256541 |
| IV Ketorolac | Other | Phase PHASE4 | Chronic Pelvic Pain | UNKNOWN | NCT01514175 |
| IV Ibuprofen | Other | Phase PHASE4 | Chronic Pelvic Pain | UNKNOWN | NCT01514175 |
| conivaptan hydrochloride | Other | Phase PHASE1 | Liver Disease | COMPLETED | NCT01370148 |
| Acetadote | Other | Phase PHASE3 | Acetaminophen Overdose | TERMINATED | NCT01118663 |
| Acetadote EF (Ethylenediaminetetraacetic Acid (EDTA) - Free) | Other | Phase PHASE3 | Acetaminophen Overdose | TERMINATED | NCT01118663 |
| Crystalline Lactulose | Other | Phase PHASE2 | Colonoscopy | COMPLETED | NCT01650870 |
| IV Placebo | Other | Phase PHASE3 | Postoperative Pain | UNKNOWN | NCT01297829 |
| Intravenous Ibuprofen | Other | Phase PHASE3 | Postoperative Pain | UNKNOWN | NCT01297829 |
| Reduction of barriers | Other | Approved | Human Papillomavirus | COMPLETED | NCT01526551 |
| HPV Vaccine and HPV-related Health Education | Other | Approved | Human Papillomavirus | COMPLETED | NCT01526551 |
| Reduction of barriers | Other | Approved | Human Papillomavirus | COMPLETED | NCT01526551 |
| HPV Vaccine and HPV-related Health Education | Other | Approved | Human Papillomavirus | COMPLETED | NCT01526551 |
| Split dose preparation | Other | Phase PHASE2 | Colonoscopy Preparation | COMPLETED | NCT01887470 |
| Full dose preparation | Other | Phase PHASE2 | Colonoscopy Preparation | COMPLETED | NCT01887470 |
| Saline | Other | Phase PHASE4 | Obesity | COMPLETED | NCT01707251 |
| Intravenous Ibuprofen | Other | Phase PHASE4 | Obesity | COMPLETED | NCT01707251 |
| Squalamine Lactate Ophthalmic Solution, 0.2% | Other | Phase PHASE1 | Retinal Vein Occlusion | COMPLETED | NCT02614937 |
| ranibizumab | Other | Phase PHASE1 | Retinal Vein Occlusion | COMPLETED | NCT02614937 |
| Squalamine Lactate Ophthalmic Solution, 0.2% | Other | Phase PHASE1 | Retinal Vein Occlusion | COMPLETED | NCT02614937 |
| ranibizumab | Other | Phase PHASE1 | Retinal Vein Occlusion | COMPLETED | NCT02614937 |
| Squalamine Lactate Ophthalmic Solution, 0.2% | Other | Phase PHASE1 | Retinal Vein Occlusion | COMPLETED | NCT02614937 |
| ranibizumab | Other | Phase PHASE1 | Retinal Vein Occlusion | COMPLETED | NCT02614937 |
| 180 grams of Crystalline Lactulose | Other | Phase PHASE2 | Colonoscopy Preparation | COMPLETED | NCT02123017 |
| 135 grams of Crystalline Lactulose | Other | Phase PHASE2 | Colonoscopy Preparation | COMPLETED | NCT02123017 |
| 90 grams of Crystalline Lactulose | Other | Phase PHASE2 | Colonoscopy Preparation | COMPLETED | NCT02123017 |
| Caldolor | Other | Phase PHASE4 | Pain | COMPLETED | NCT01773005 |
| Ofirmev | Other | Phase PHASE4 | Pain | COMPLETED | NCT01773005 |
| Placebo | Other | Phase PHASE3 | Hyponatremia | TERMINATED | NCT01451411 |
| Conivaptan hydrochloride | Other | Phase PHASE3 | Hyponatremia | TERMINATED | NCT01451411 |
| Ketorolac | Other | Phase PHASE4 | Pain | COMPLETED | NCT01901393 |
| IV ibuprofen | Other | Phase PHASE4 | Pain | COMPLETED | NCT01901393 |
| IV ketorolac | Other | Phase PHASE4 | Arthroscopic Knee Surgery | COMPLETED | NCT01650519 |
| IV ibuprofen | Other | Phase PHASE4 | Arthroscopic Knee Surgery | COMPLETED | NCT01650519 |
| Normal Saline | Other | Phase PHASE3 | Tonsillectomy | COMPLETED | NCT01332253 |
| Intravenous ibuprofen | Other | Phase PHASE3 | Tonsillectomy | COMPLETED | NCT01332253 |
| acetaminophen | Other | Phase PHASE3 | Fever | COMPLETED | NCT01002573 |
| ibuprofen | Other | Phase PHASE3 | Fever | COMPLETED | NCT01002573 |
| Placebo | Other | Phase PHASE2 | Hepatorenal Syndrome | COMPLETED | NCT01436500 |
| Ifetroban Injection | Other | Phase PHASE2 | Hepatorenal Syndrome | COMPLETED | NCT01436500 |
| Placebo, Oral Capsule | Other | Phase PHASE2 | Aspirin Exacerbated Respiratory Disease (AERD) | COMPLETED | NCT02216357 |
| Ifetroban, Oral Capsule | Other | Phase PHASE2 | Aspirin Exacerbated Respiratory Disease (AERD) | COMPLETED | NCT02216357 |
| Acetaminophen (Standard of Care) | Other | Phase PHASE4 | Fever | TERMINATED | NCT01530880 |
| Intravenous Ibuprofen | Other | Phase PHASE4 | Fever | TERMINATED | NCT01530880 |
| telavancin | Other | Phase PHASE1 | Kidney Diseases | COMPLETED | NCT01238796 |
| Telavancin Injection | Other | Phase PHASE4 | Cystic Fibrosis | COMPLETED | NCT03172793 |
| VIBATIV | Other | Preclinical | Pregnancy | WITHDRAWN | NCT01130324 |
| Ibuprofen | Other | Phase PHASE4 | Pain | COMPLETED | NCT02583399 |
| Placebo | Other | Phase PHASE2 | Portal Hypertension | COMPLETED | NCT02802228 |
| Ifetroban | Other | Phase PHASE2 | Portal Hypertension | COMPLETED | NCT02802228 |
| Atorvastatin injection | Other | Phase PHASE2 | Hypercholesterolemia | COMPLETED | NCT03611010 |
| Intravenous ibuprofen | Other | Phase PHASE4 | Pain | COMPLETED | NCT01334944 |
| Data Collection | Other | Preclinical | Acute Coronary Syndrome | COMPLETED | NCT03494556 |
| Data Collection | Other | Preclinical | Acute Coronary Syndrome | COMPLETED | NCT03494556 |
| Data Collection | Other | Preclinical | Acute Coronary Syndrome | COMPLETED | NCT03494556 |
| Intravenous ibuprofen | Other | Phase PHASE4 | Pain | COMPLETED | NCT01334957 |
| Telavancin | Other | Phase PHASE1 | Gram-Positive Bacterial Infections | TERMINATED | NCT02013141 |
| Placebo | Other | Phase PHASE2 | Malignant Solid Tumor | ACTIVE_NOT_RECRUITING | NCT03694249 |
| Ifetroban Sodium | Other | Phase PHASE2 | Malignant Solid Tumor | ACTIVE_NOT_RECRUITING | NCT03694249 |
| Placebo Oral Capsule | Other | Phase PHASE2 | Asthma, Aspirin-Induced | COMPLETED | NCT03028350 |
| Ifetroban Oral Capsule | Other | Phase PHASE2 | Asthma, Aspirin-Induced | COMPLETED | NCT03028350 |
| Placebo | Other | Phase PHASE2 | Cardiovascular Diseases | COMPLETED | NCT03962855 |
| Ifetroban Sodium | Other | Phase PHASE2 | Cardiovascular Diseases | COMPLETED | NCT03962855 |
| Telavancin Injection | Other | Phase PHASE4 | Subarachnoid Hemorrhage, Aneurysmal | RECRUITING | NCT06119061 |
| Placebo | Other | Phase PHASE2 | Idiopathic Pulmonary Fibrosis | RECRUITING | NCT05571059 |
| Ifetroban Sodium | Other | Phase PHASE2 | Idiopathic Pulmonary Fibrosis | RECRUITING | NCT05571059 |
| Placebo | Other | Phase PHASE2 | Duchenne Muscular Dystrophy Cardiomyopathy | COMPLETED | NCT03340675 |
| Ifetroban | Other | Phase PHASE2 | Duchenne Muscular Dystrophy Cardiomyopathy | COMPLETED | NCT03340675 |
| Oral Placebo | Other | Phase PHASE2 | Scleroderma, Diffuse | ACTIVE_NOT_RECRUITING | NCT02682511 |
| Oral Ifetroban | Other | Phase PHASE2 | Scleroderma, Diffuse | ACTIVE_NOT_RECRUITING | NCT02682511 |
| Ifetroban Sodium | DRUG | Phase PHASE2 | Idiopathic Pulmonary Fibrosis | RECRUITING | NCT05571059 |
| Atorvastatin injection | DRUG | Phase PHASE2 | Hypercholesterolemia | COMPLETED | NCT03611010 |
| Telavancin Injection | DRUG | Phase PHASE4 | Subarachnoid Hemorrhage, Aneurysmal | RECRUITING | NCT06119061 |
| Placebo Oral Capsule | DRUG | Phase PHASE2 | Asthma, Aspirin-Induced | COMPLETED | NCT03028350 |
| Ifetroban Oral Capsule | DRUG | Phase PHASE2 | Asthma, Aspirin-Induced | COMPLETED | NCT03028350 |
| Ifetroban | DRUG | Phase PHASE2 | Duchenne Muscular Dystrophy Cardiomyopathy | COMPLETED | NCT03340675 |
| Oral Placebo | DRUG | Phase PHASE2 | Scleroderma, Diffuse | ACTIVE_NOT_RECRUITING | NCT02682511 |
| Oral Ifetroban | DRUG | Phase PHASE2 | Scleroderma, Diffuse | ACTIVE_NOT_RECRUITING | NCT02682511 |
| Squalamine Lactate Ophthalmic Solution, 0.2% | DRUG | Phase PHASE1 | Retinal Vein Occlusion | COMPLETED | NCT02614937 |
| ranibizumab | DRUG | Phase PHASE1 | Retinal Vein Occlusion | COMPLETED | NCT02614937 |
| Vibativ | DRUG | Preclinical | Hospital Acquired Bacterial Pneumonia | COMPLETED | NCT02288234 |
| Placebo, Oral Capsule | DRUG | Phase PHASE2 | Aspirin Exacerbated Respiratory Disease (AERD) | COMPLETED | NCT02216357 |
| Ifetroban, Oral Capsule | DRUG | Phase PHASE2 | Aspirin Exacerbated Respiratory Disease (AERD) | COMPLETED | NCT02216357 |
| Cefazolin | DRUG | Phase PHASE3 | Bacteremia | TERMINATED | NCT02208063 |
| Synthetic penicillin | DRUG | Phase PHASE3 | Bacteremia | TERMINATED | NCT02208063 |
| Daptomycin | DRUG | Phase PHASE3 | Bacteremia | TERMINATED | NCT02208063 |
| 180 grams of Crystalline Lactulose | DRUG | Phase PHASE2 | Colonoscopy Preparation | COMPLETED | NCT02123017 |
| 135 grams of Crystalline Lactulose | DRUG | Phase PHASE2 | Colonoscopy Preparation | COMPLETED | NCT02123017 |
| 90 grams of Crystalline Lactulose | DRUG | Phase PHASE2 | Colonoscopy Preparation | COMPLETED | NCT02123017 |
| Ketorolac | DRUG | Phase PHASE4 | Pain | COMPLETED | NCT01901393 |
| Split dose preparation | DRUG | Phase PHASE2 | Colonoscopy Preparation | COMPLETED | NCT01887470 |
| Full dose preparation | DRUG | Phase PHASE2 | Colonoscopy Preparation | COMPLETED | NCT01887470 |
| Ofirmev | DRUG | Phase PHASE4 | Pain | COMPLETED | NCT01773005 |
| Saline | DRUG | Phase PHASE4 | Obesity | COMPLETED | NCT01707251 |
| Crystalline Lactulose | DRUG | Phase PHASE2 | Colonoscopy | COMPLETED | NCT01650870 |
| IV ketorolac | DRUG | Phase PHASE4 | Arthroscopic Knee Surgery | COMPLETED | NCT01650519 |
| IV ibuprofen | DRUG | Phase PHASE4 | Pain | COMPLETED | NCT01901393 |
| Acetaminophen (Standard of Care) | DRUG | Phase PHASE4 | Fever | TERMINATED | NCT01530880 |
| IV Ketorolac | DRUG | Phase PHASE4 | Chronic Pelvic Pain | UNKNOWN | NCT01514175 |
| IV Ibuprofen | DRUG | Phase PHASE4 | Chronic Pelvic Pain | UNKNOWN | NCT01514175 |
| Conivaptan hydrochloride | DRUG | Phase PHASE3 | Hyponatremia | TERMINATED | NCT01451411 |
| Ifetroban Injection | DRUG | Phase PHASE2 | Hepatorenal Syndrome | COMPLETED | NCT01436500 |
| IV Placebo | OTHER | Phase PHASE3 | Postoperative Pain | UNKNOWN | NCT01297829 |
| Intravenous Ibuprofen | DRUG | Phase PHASE4 | Obesity | COMPLETED | NCT01707251 |
| Kristalose | DRUG | Phase PHASE1 | Bowel Evacuant Prior to Colonoscopy | COMPLETED | NCT01256541 |
| telavancin | DRUG | Phase PHASE1 | Kidney Diseases | COMPLETED | NCT01238796 |
| VIBATIV | DRUG | Preclinical | Pregnancy | WITHDRAWN | NCT01130324 |
| Acetadote | DRUG | Phase EARLY_PHASE1 | Glioblastoma | NOT_YET_RECRUITING | NCT07387666 |
| Acetadote EF (Ethylenediaminetetraacetic Acid (EDTA) - Free) | DRUG | Phase PHASE3 | Acetaminophen Overdose | TERMINATED | NCT01118663 |
| acetaminophen | DRUG | Phase PHASE3 | Fever | COMPLETED | NCT01002573 |
| ibuprofen | DRUG | Phase PHASE3 | Fever | COMPLETED | NCT01002573 |
| intravenous NAC | DRUG | Phase PHASE4 | Nephropathy | UNKNOWN | NCT00939913 |
| glutathione, vit C and NAC | DRUG | Approved | Autism | COMPLETED | NCT00889538 |
| glutathione | DRUG | Approved | Autism | COMPLETED | NCT00889538 |
| IVIb | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT00867880 |
| conivaptan hydrochloride | DRUG | Phase PHASE1 | Liver Disease | COMPLETED | NCT01370148 |
| 0.9% Sodium-chloride | DRUG | Phase PHASE2 | Radiocontrast Nephropathy | COMPLETED | NCT00780962 |
| N-Acetylcysteine (NAC) | DRUG | Phase PHASE2 | Radiocontrast Nephropathy | COMPLETED | NCT00780962 |
| YM087 | DRUG | Phase PHASE3 | Hyponatremia | COMPLETED | NCT00380575 |
| vancomycin or antistaphylococcal penicillin | DRUG | Phase PHASE2 | Infections, Gram-positive Bacterial | COMPLETED | NCT00077675 |
| liquid lactulose | DRUG | Phase PHASE4 | Constipation | COMPLETED | NCT00712543 |
| lactulose (Kristalose®) | DRUG | Phase PHASE4 | Constipation | COMPLETED | NCT00712543 |
| YM087 oral | DRUG | Phase PHASE3 | Hyponatremia | COMPLETED | NCT00492037 |
| Placebo | DRUG | Phase PHASE2 | Idiopathic Pulmonary Fibrosis | RECRUITING | NCT05571059 |
| Indomethacin | DRUG | Phase PHASE4 | Ductus Arteriosus, Patent | WITHDRAWN | NCT00470743 |
| Ibuprofen | DRUG | Phase PHASE4 | Pain | COMPLETED | NCT02583399 |
| Normal Saline | OTHER | Phase PHASE3 | Tonsillectomy | COMPLETED | NCT01332253 |
| Conivaptan | DRUG | Phase PHASE3 | Hyponatremia | COMPLETED | NCT00478192 |
| Intravenous ibuprofen | DRUG | Phase PHASE4 | Pain | COMPLETED | NCT01334957 |
| Normal saline as placebo comparator | OTHER | Phase PHASE3 | Pain | COMPLETED | NCT00225732 |
| Caldolor | DRUG | Phase PHASE4 | Pain | COMPLETED | NCT01773005 |
| Vancomycin | DRUG | Phase PHASE3 | Bacteremia | TERMINATED | NCT02208063 |
| Vancomycin, nafcillin, oxacillin, or cloxacillin | DRUG | Phase PHASE2 | Gram-Positive Bacterial Infections | COMPLETED | NCT00062647 |
| Vancomycin or antistaphylococcal penicillin | DRUG | Phase PHASE2 | Infections, Gram-Positive Bacterial | COMPLETED | NCT00061633 |
| Telavancin | DRUG | Phase PHASE3 | Bacteremia | TERMINATED | NCT02208063 |
| placebo | DRUG | Approved | Autism | COMPLETED | NCT00889538 |
| conivaptan | DRUG | Phase PHASE3 | Hyponatremia | TERMINATED | NCT00843986 |
Total products: 145